New eye drops aim to boost blood flow for vision conditions
NCT ID NCT07354477
Summary
This is a small, early-stage study testing whether a new eye drop called QLS-111 can improve blood flow and widen blood vessels in the back of the eye. It will involve 14 people with non-proliferative diabetic retinopathy, open-angle glaucoma, or normal tension glaucoma. Participants will use the eye drops in both eyes twice daily for two weeks while researchers measure changes in their eye's blood vessels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPEN-ANGLE GLAUCOMA (OAG) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Stanford University, Dept. of Ophthalmology
RECRUITINGPalo Alto, California, 94303, United States
Conditions
Explore the condition pages connected to this study.